A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Funding from the ALS Association and the Tow Foundation will be used by the New York Genome Center to determine the entire genetic sequence of people with ALS who donated their tissues after death.
Kyle Allison, recipient of the NIH Director’s Early Independence Award, is exploring how to keep common bacterial infections from becoming chronic illnesses.
Columbia pediatric orthopedic surgeon David P. Roye is part of a team that has designed a flexible brace with sensors to help its users with everyday activities.